Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Molecular subsets in the gene expression signatures of scleroderma skin.

Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, Whitfield ML.

PLoS One. 2008 Jul 16;3(7):e2696. doi: 10.1371/journal.pone.0002696. Erratum in: PLoS ONE. 2008;3(10). doi: 10.1371/annotation/05bed72c-c6f6-4685-a732-02c78e5f66c2.

2.

A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity.

Sargent JL, Milano A, Bhattacharyya S, Varga J, Connolly MK, Chang HY, Whitfield ML.

J Invest Dermatol. 2010 Mar;130(3):694-705. doi: 10.1038/jid.2009.318. Epub 2009 Oct 8.

3.

Differential expression of tissue kallikrein in the skin of systemic sclerosis.

Milia AF, Del Rosso A, Pacini A, Manetti M, Marrelli A, Nosi D, Giacomelli R, Matucci-Cerinic M, Ibba-Manneschi L.

Histol Histopathol. 2005 Apr;20(2):415-22. doi: 10.14670/HH-20.415.

PMID:
15736045
4.

Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.

Farina G, Lemaire R, Pancari P, Bayle J, Widom RL, Lafyatis R.

Ann Rheum Dis. 2009 Mar;68(3):435-41. doi: 10.1136/ard.2007.086850. Epub 2008 Apr 13.

PMID:
18408251
5.

Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis.

Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R.

Rheumatology (Oxford). 2003 Nov;42(11):1295-8. Epub 2003 Jul 16.

PMID:
12867583
6.

Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.

Altorok N, Tsou PS, Coit P, Khanna D, Sawalha AH.

Ann Rheum Dis. 2015 Aug;74(8):1612-20. doi: 10.1136/annrheumdis-2014-205303. Epub 2014 May 8.

7.

Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β.

Tanaka S, Suto A, Ikeda K, Sanayama Y, Nakagomi D, Iwamoto T, Suzuki K, Kambe N, Matsue H, Matsumura R, Kashiwakuma D, Iwamoto I, Nakajima H.

Rheumatology (Oxford). 2013 Nov;52(11):1963-72. doi: 10.1093/rheumatology/ket254. Epub 2013 Jul 27.

PMID:
23893664
8.

Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.

Corallo C, Paulesu L, Cutolo M, Ietta F, Carotenuto C, Mannelli C, Romagnoli R, Nuti R, Giordano N.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S98-105. Epub 2015 May 25.

PMID:
26005773
9.

Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis.

Manneschi LI, Del Rosso A, Milia AF, Tani A, Nosi D, Pignone A, Generini S, Giacomelli R, Cerinic MM.

Rheumatology (Oxford). 2005 May;44(5):607-13. Epub 2005 Feb 22.

PMID:
15728417
10.

Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.

Dooley A, Gao B, Bradley N, Abraham DJ, Black CM, Jacobs M, Bruckdorfer KR.

Rheumatology (Oxford). 2006 Jun;45(6):676-84. Epub 2006 Jan 6.

PMID:
16399843
11.

Increased messenger RNA levels of the mesenchymal cadherin-11 in the peripheral blood of systemic sclerosis patients correlate with diffuse skin involvement.

Christopoulos PF, Bournia VK, Panopoulos S, Vaiopoulos A, Koutsilieris M, Sfikakis PP.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S36-9. Epub 2015 Jun 29.

PMID:
26121083
12.

A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.

Taroni JN, Greene CS, Martyanov V, Wood TA, Christmann RB, Farber HW, Lafyatis RA, Denton CP, Hinchcliff ME, Pioli PA, Mahoney JM, Whitfield ML.

Genome Med. 2017 Mar 23;9(1):27. doi: 10.1186/s13073-017-0417-1.

13.

Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients.

Arakawa H, Jinnin M, Muchemwa FC, Makino T, Kajihara I, Makino K, Honda N, Sakai K, Fukushima S, Ihn H.

Exp Dermatol. 2011 Sep;20(9):764-6. doi: 10.1111/j.1600-0625.2011.01310.x. Epub 2011 May 25.

PMID:
21615510
14.

Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.

Hasegawa M, Sato S, Takehara K.

Arch Dermatol Res. 2004 Jul;296(2):89-93. Epub 2004 May 7.

PMID:
15133694
15.

Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1.

Lemaire R, Burwell T, Sun H, Delaney T, Bakken J, Cheng L, Rebelatto MC, Czapiga M, de-Mendez I, Coyle AJ, Herbst R, Lafyatis R, Connor J.

Arthritis Rheumatol. 2016 Feb;68(2):473-83. doi: 10.1002/art.39443.

16.

Systemic and cell type-specific gene expression patterns in scleroderma skin.

Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi JT, Pergamenschikov A, McCalmont TH, Brown PO, Botstein D, Connolly MK.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12319-24. Epub 2003 Oct 6.

17.

Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.

Derrett-Smith EC, Martyanov V, Chighizola CB, Moinzadeh P, Campochiaro C, Khan K, Wood TA, Meroni PL, Abraham DJ, Ong VH, Lafyatis R, Whitfield ML, Denton CP.

Arthritis Res Ther. 2017 Jul 4;19(1):156. doi: 10.1186/s13075-017-1360-7.

18.

Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies.

Pendergrass SA, Lemaire R, Francis IP, Mahoney JM, Lafyatis R, Whitfield ML.

J Invest Dermatol. 2012 May;132(5):1363-73. doi: 10.1038/jid.2011.472. Epub 2012 Feb 9.

19.

Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts.

Johnson ME, Mahoney JM, Taroni J, Sargent JL, Marmarelis E, Wu MR, Varga J, Hinchcliff ME, Whitfield ML.

PLoS One. 2015 Jan 21;10(1):e0114017. doi: 10.1371/journal.pone.0114017. eCollection 2015.

20.

Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.

Muangchan C, Harding S, Khimdas S, Bonner A; Canadian Scleroderma Research group, Baron M, Pope J.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14. doi: 10.1002/acr.21716.

Supplemental Content

Support Center